The Alliance

Insight Series

The Alliance insight series offers critical resources for stakeholders across the donation and transplantation continuum. For each topic, you can find related action items, tools, and references.

The Alliance Insight Series

Feedback & Suggestions Welcome

Your input is valuable to us as it helps improve our programs and offerings in order to provide you with vital updates and essential information. Please feel free to share your thoughts and ideas with us.

TxQualityCorner Logo Blue

SEPTEMBER 2024  |  ISSUE 2

NoNew Nuances Cover Banner 1200x715

Background

In August 2022, the OPTN aligned its policies with the U.S. 2020 Public Health Service (PHS) Guideline for assessing all transplant candidates for Hepatitis B vaccination.

Education

POLICY INTERPRETATION | OPTN POLICY 15.2: CANDIDATE PRE-TRANSPLANT TESTING REQUIREMENTS
WHATWHENREMINDERS
  • Assessment of the candidate’s HBV vaccination status
  • Reporting of candidate’s vaccination status to OPTN
  • If vaccination cannot be initiated or completed, the reason for not initiating or completing the HBV vaccination must be documented and reported to OPTN.
Part of medical evaluation prior to transplantThe assessment of HBV vaccination status (i.e., review of vaccination records, titers) must be explicitly stated in the medical record.
HBV: Hepatitis B Virus

Action

1. Improving Compliance Through Process

a. Leveraging EMR tools to create standardized documentation

  1. EPIC: Use of Smartphrase including HBV vaccination history, HBV titer results, patient vaccination status, and rationale mirroring TIEDI reporting fields
  2. Matching Epic deferral immunization nomenclature with TIEDI options.
Screenshot 2024 09 14 At 11.04.21 AM
Screenshot 2024 09 14 At 11.04.34 AM

2. Improving Compliance Through Monitoring

a. Creation of check list tasks and tracking report in Epic- can be utilized by coordinators and quality team to track compliance.
b. Auditing by transplant quality teams including reporting out on compliance rates and educating when noncompliance is noted.

Lessons Learned on the Journey Toward Compliance

    1. Be aware of what kind of HBsAb testing (quantitative vs qualitative testing) is being ordered. Quantitative testing is often preferred as numerical value will better illustrate the level of immunity.

    2. HBV vaccination series completion is dependent on the product that is received.  Any supporting documentation supporting completion of vaccination series should include information regarding all doses of vaccination.

    3. TIEDI Reporting Requirements

TIEDI FORM
TIEDI FORMWHAT TO REPORTWHERE TO REPORT
Transplant Recipient Registration (TRR)Assessment of HBV Vaccination Status Prior to Transplant for All Recipients

Picture11N

If a patient has received a full Hepatitis B vaccination series prior to transplant, select Yes. If unknown, select UNK.

If ‘No’ is selected, select the reason from the list:

  • Immunity: seropositive based on lab assay
  • Medical precaution: not vaccinated due to medical constraints
  • Time constraints: has not received series or full series due to urgency of transplant
  • Patient objection
  • Product out of stock

Other, specify: Select this option if series is still in progress of completion & indicate “series still in progress.” This option may be used for any other reason that is not listed in options above.

OPTN Survey Readiness

1. Provide documentation that:

  1. An assessment (and date of assessment) of the need for HBV vaccination prior to transplant and reason for not initiation or completing HBV vaccination series (if indicated)
  2. Vaccination status prior to transplant in medical records is consistent with the vaccination status reported in TIEDI
Picture12N
Picture13N

A SPECIAL THANKS TO THIS ISSUE’S CONTRIBUTORS

We would like to express our sincerest gratitude for our contributors’ tireless efforts on making Transplant Quality Corner a reality. Their dedication and expertise have been an invaluable contribution to the successful launch of this project. We are incredibly grateful for all their hard work and commitment.

Elizabeth Friddell
Elizabeth Friddell
Site SurveyorUNOS
Tamika Watkins
Tamika Watkins
Disease Transmission Advisory CommitteeUNOS

A SPECIAL THANKS TO THE TRANSPLANT QUALITY CORNER WORKGROUP

D. Chen Headshot
Denisia Chen
RN, CHC, CPCTransplant Regulatory Compliance SpecialistStanford Medicine Children's Health
Abbey Olsen
Abbey Olsen
MSN, RN, CCRNTransplant Quality ManagerUniversity of Utah Hospital
Deepa Kurup
Deepa Kurup
RN, MSN/MBA, LSSBB, CPHQSenior Director, Center for TransplantationUC San Diego Health System
Be203ac2ecb9dfdfee91b13682e8260f
Melissa Robinson
Quality & Safety Director, Transplant Institute Loma Linda University Medical Center
Lawson Jenna Silo 1
Jenna Lawson
MSSenior Quality and Patient Safety AdvisorVanderbilt University Medical Center
Hellen Oduor Headshot
Hellen Oduor
Quality DirectorMethodist Dallas Medical Center
Ff 4ab2fbf66829b830ecca7eee90f146cb Ff Smith Lindsay
Lindsay Smith
RN, MSNTransplant Quality DirectorVanderbilt University Medical Center

FEEDBACK

If there is content you feel that should be added or was lacking, we would like to hear from you. Positive feedback on what is working for you, is also welcomed. Thank you for taking the time to provide us with your feedback.

Insights Feedback Form